PULM
Pulmatrix Inc
NASDAQ · Pharmaceuticals
$2.48
-0.01 (-0.40%)
Open$2.50
Previous Close$2.49
Day High$2.60
Day Low$2.48
52W High$4.64
52W Low$3.43
Volume—
Avg Volume264.9K
Market Cap9.06M
P/E Ratio23.18
EPS$0.19
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+83.1% upside
Current
$2.48
$2.48
Target
$4.54
$4.54
$3.16
$4.54 avg
$6.69
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.36M | 1.27M | 1.06M |
| Net Income | 333.6K | 357.5K | 314.0K |
| Profit Margin | 24.6% | 28.2% | 29.6% |
| EBITDA | 634.9K | 531.9K | 486.7K |
| Free Cash Flow | 335.1K | 275.9K | 324.6K |
| Rev Growth | +18.9% | -7.0% | +4.1% |
| Debt/Equity | 0.78 | 0.71 | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |